DUPIXENT

Google image searchProduct monograph

Active ingredient

dupilumab, 300 MG/2 ML

DIN: 02510049

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PRE-FILLED PEN. SINGLE-USE

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 27-MAY-2021

ATC:

• D11 — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD, )
• D11A — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD)
• D11AH — Agents for atopic dermatitis, excluding corticosteroides (ATC, ATC/DDD)
• D11AH05 — DUPILUMAB (ATC/DDD)

Reference brand drug: Dupixent

External Links for Dupixent

Search on Google

• Dupixent side effects
• Dupixent dosage
• dupilumab side effects
• dupilumab dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find dupixent photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.